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Abstract
A large percentage of the population may be expected to experience painful symptoms or disability associated with
intervertebral disc (IVD) degeneration – a condition characterized by diminished integrity of tissue components. Great
interest exists in the use of autologous or allogeneic cells delivered to the degenerated IVD to promote matrix
regeneration. Induced pluripotent stem cells (iPSCs), derived from a patient’s own somatic cells, have demonstrated
their capacity to differentiate into various cell types although their potential to differentiate into an IVD cell has not yet
been demonstrated. The overall objective of this study was to assess the possibility of generating iPSC-derived
nucleus pulposus (NP) cells in a mouse model, a cell population that is entirely derived from notochord. This study
employed magnetic activated cell sorting (MACS) to isolate a CD24+ iPSC subpopulation. Notochordal cell-related
gene expression was analyzed in this CD24+ cell fraction via real time RT-PCR. CD24+ iPSCs were then cultured in a
laminin-rich culture system for up to 28 days, and the mouse NP phenotype was assessed by immunostaining. This
study also focused on producing a more conducive environment for NP differentiation of mouse iPSCs with addition
of low oxygen tension and notochordal cell conditioned medium (NCCM) to the culture platform. iPSCs were
evaluated for an ability to adopt an NP-like phenotype through a combination of immunostaining and biochemical
assays. Results demonstrated that a CD24+ fraction of mouse iPSCs could be retrieved and differentiated into a
population that could synthesize matrix components similar to that in native NP. Likewise, the addition of a hypoxic
environment and NCCM induced a similar phenotypic result. In conclusion, this study suggests that mouse iPSCs
have the potential to differentiate into NP-like cells and suggests the possibility that they may be used as a novel cell
source for cellular therapy in the IVD.
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Introduction
The healthy intervertebral disc (IVD) relies upon the well
hydrated and proteoglycan-rich nucleus pulposus (NP) tissue
to support and distribute the loads of spinal mobility and joint
loading [1,2]. The immature nucleus pulposus contains more
than 85% water, and a high density of randomly organized type
II collagen fibers with lesser amounts of collagen types III, V,
VI, and IX, elastin, and laminins type 111, 511 and 332 [3-8].
This compositionally unique extracellular matrix (ECM) is
generated and maintained by a unique population of NP cells
which express phenotypic markers that suggest their
notochordal origin, including specific cytokeratins, vimentin,
transcription factor (Brachyury, T) and cell surface marker
(CD24) [9-14]. While this NP cell phenotype is associated with
development and growth, there may be a shift towards a more
sparse population of chondrocyte-like cells in the NP with aging
[15]. IVD function may become compromised with aging-
associated degeneration or in pathologies such as IVD
herniation, processes that are associated with loss of disc
height, decreased hydration, and a dramatic loss of cellularity
believed to be key to the progressive nature of IVD pathology
[16]. IVD disorders may contribute to pain and disability is a
large number of patients, afflicting over 80% of adults and
responsible for a socioeconomic toll of $100 billion annually in
the United States alone [16-18]. These staggering
consequences prompt a better understanding of the
mechanisms governing IVD pathology, and more importantly,
the invention of strategies that would stimulate its repair.
Cell-based tissue regeneration has emerged as an area of
tremendous interest, with studies reporting matrix regenerative
potential for many cell sources, including autologous
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chondrocytes, primary IVD cells and stem cells [19-21]. The
question of cell source is of particular importance for cell-based
IVD regeneration, given that the availability of autologous disc
cells is extremely low in the adult, and that the mature adult
phenotype may differ substantially from that of the immature
IVD cell. In early work, autologous or allogeneic NP cells were
isolated, expanded and re-implanted at high cell numbers in
animal IVDs, demonstrating some beneficial effects in inhibiting
the degenerative changes of nucleotomy [22-25]. Autologous
disc cell transplantation has also been evaluated in clinical
trials for follow-up treatment to discectomy [26], leading to the
emergence of clinical products and platforms that support
autologous cell supplementation to the IVD. Given the very
limited availability of native and healthy IVD cells that can be
harvested for therapy, however, there has been interest in
using stem cell sources with a particular focus on bone
marrow-derived mesenchymal stem cells (MSCs) [27,28] as
well as adult stem cells [29,30]. The in vitro differentiation of
MSCs into NP-like or chondrocyte-like cells has been
demonstrated under hypoxic and high osmotic pressure
conditions, along with transforming growth factor (TGF)-β and
notochordal cell conditioned medium stimulation [28,31,32]. In
those studies, limited knowledge of unique NP phenotypic
markers has impaired a clear demonstration of the MSC
differentiation potential into an NP-like cell lineage [33,34].
Preclinical studies have followed injection of autologous MSCs
embedded in atelocollagen gel as well as direct injection of
MSCs into rabbit or rat models of IVD degeneration, and
detected an ability of these cells to differentiate or regenerate a
hydrated and proteoglycan-rich matrix [35,36]. These findings
have supported the expanded use of autologous MSCs in
clinical trials for IVD disorders, despite adverse effects
associated with donor site harvest and ex vivo cell expansion.
Consequently, the need to identify additional cell sources
supportive of regeneration of NP-like tissue remains of great
interest.
In 2006, Takahashi and Yamanaka demonstrated that
mouse embryonic fibroblasts could be reprogrammed into
pluripotent stem cells via retroviral transfection of four
transcription factors: Oct3/4, Sox2, c-Myc and Klf4 [37]. This
was subsequently proven feasible in fibroblasts from humans
[38], rhesus monkeys [39], pigs [40], and rats [41]. Induced
pluripotent stem cells (iPSCs) resemble embryonic stem cells
(ESCs) functionally, differentiating into cells from all three germ
layers – ectoderm, endoderm, and mesoderm. iPSCs alleviate
ethical concerns tied to usage of ESCs, in addition to
representing a possible autologous source for individualized
treatments. It is well recognized now that iPSCs derived from a
patient’s own somatic cells represent an attractive cell source,
having the potential to differentiate into various cell types
including neurons [42,43], cardiomyocytes [44,45], and cells of
a hematopoietic lineage [46]. Of relevance to the proposed
work are studies demonstrating the ability to promote
differentiation of mouse or human iPSCs into chondrocyte-like
cells, facilitated by supplemental growth factors that include
bone morphogenetic proteins (BMPs) or TGFs [47-49]. These
studies have demonstrated an ability for differentiated iPSCs to
synthesize and express type II collagen and aggrecan – key
components of both cartilage and NP ECM. These findings
highlight the potential of using iPSCs as a source for
generating differentiated NP-like cells, but also point out a need
for identifying those factors that can promote expression of
markers specific to the NP cell phenotype. In the mouse,
studies have shown that the NP appears to consist entirely of
notochordal cells which are retained into adulthood [50,51] and
other studies with lineage-tracing techniques have also shown
that all NP cells are originated from notochord [52,53]. For the
reason that the mouse NP cell retains many features of the
notochordally-derived cell, markers that relate to a notochordal
cell phenotype may be used to test if mouse iPSCs can
differentiate into mouse NP cells. This approach and interest
forms the basis for this proposed study.
In prior studies, we reported that human umbilical cord-
derived MSCs can differentiate into NP-like cells using a
Matrigel-based (laminin-rich) culture system [33]. While the
mechanisms regulating this cell differentiation remain largely
unknown, the presence of the laminin ligand in the matrix and
soft stiffness of the Matrigel substrate itself appear to match
important characteristics of the native NP tissue for immature
porcine NP. Culture of immature porcine NP cells under these
conditions can maintain mainly notochordal-like NP cells,
promote matrix biosynthesis, and maintain NP cell cluster
morphology as well as NP unique marker expression (i.e.
laminin 511 and specific integrin receptors) [8,33,54]. Herein,
we perform studies using mouse iPSCs cultured in this similar
laminin-rich environment to determine if these conditions can
similarly promote expression of a unique notochordal-like NP
cell phenotype. We first evaluated the expression of NP
precursor markers in populations of mouse iPSCs cultured in
vitro prior to differentiation or following spontaneous
differentiation into embryoid bodies (EBs). We identified a
subpopulation of CD24+ cells, indicative of NP precursor cells
[13] in undifferentiated iPSCs. We then isolated these
subpopulations of CD24+ iPSCs via magnetic activated cell
sorting (MACS), to test the potential for this enriched CD24+
fraction to promote appropriate NP matrix regeneration in a
laminin-rich culture system. Separately, unsorted iPSCs were
studied for potential enhancement to the differentiation process
of iPSCs towards an notochordal-like NP cell fate using select
environmental conditions of low oxygen tension (hypoxia) [28]
and notochordal cell-conditioned medium (NCCM) [31,32,55]
under the same laminin-rich culture conditions.
Materials and Methods
iPSC generation and flow cytometry analysis
Using a lentiviral gene delivery system, primary mouse
embryonic fibroblasts (MEFs, Millipore, Billerica, CA) were
stably transduced with a poly-cystronic vector containing the
inducible promoter Tet-OnTM (FU.tet.on. OSKM), which
controlled expression of the four transcription factors: Oct4,
Sox2, Klf4 and Myc as reported in the previous study [45].
Briefly, following cell transduction with the lentiviral vector cells
were cultured in stem cell culture medium containing DMEM /
High Glucose (Life Technologies, Grand Island, NY), fetal
bovine serum (15%, Atlanta Biologicals, Lawrenceville, GA),
Differentiation of iPSCs into NP Cells
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non-essential amino acids (1%, Life Technologies), sodium
pyruvate (1%, Life Technologies), Glutamax-I (1%, Life
Technologies), βMercaptoethanol (55µM, Life Technologies),
gentamicin (25µg/ml, Life Technologies), valproic acid (0.5mM,
Sigma, St. Louis, MO), leukemia inhibitory factor or LIF
(103U/ml, ESGRO®, Millipore), and Doxycycline (10µg/ml,
Sigma). Doxycycline was removed 7 days post induction of
transcription factor expression and individual iPSC colonies
were mechanically picked and expanded on a feeder layer of
mitotically inactivated mouse embryonic fibroblasts (MEFs).
Our prior work has shown that these iPSC colonies expressed
proteins of pluripotency marker (OCT4, SSEA1 and NANOG)
and were capable of differentiating into functional
cardiomyocytes [45].
For cell proliferation, undifferentiated iPSCs were seeded on
a MEF feeder layer in proliferation medium (DMEM, 20% FBS
and LIF, 1000 U/ml) and passaged twice (P2). For
spontaneous differentiation, undifferentiated cells were allowed
to form 3D embryoid bodies (EBs) in ultra-low attachment
dishes (Corning, Corning, NY) with proliferation medium w/o
LIF for 3 days (Figure 1). Gene expression for notochord-
related transcription factors (Noto, Foxa2, Shh, Brachyury,
Noggin) and the pluripotency marker Oct4 was analyzed for
both undifferentiated cells and cells in EBs via real-time RT-
PCR (see below). In addition, the expression of MSC and NP-
related biomarkers were also analyzed for both undifferentiated
cells and cells in EBs by flow cytometry. Briefly, EBs were
detached from the culture surface, and individual cells were
dissociated using 0.025% trypsin/EDTA (Lonza, Walkersville,
MD) and re-suspended in culture medium prior to antibody
labeling. Cells (0.25~0.5x106) were incubated with monoclonal
antibodies against multiple cell markers (see Table 1) and
appropriate isotype controls, followed by incubation with
fluorescently labeled secondary antibodies. Cells were
analyzed on an Accuri C6 flow cytometer (Accuri, Ann Arbor,
MI) to determine the percentage of cells with positive surface
proteins (% cells). Flow cytometry analysis was repeated for
two sets of cell preparations. The average of values for
percentage of positive cells was reported.
Enrichment of CD24+ cell population from
undifferentiated iPSCs by MACS
Freshly trypsinized mouse iPSCs (10x106 cells) were
partitioned into 1.5 mL Eppendorf tubes, and suspended in
incubation buffer (1X DPBS without Ca2+ and Mg2+, 0.5% BSA)
and rat anti-mouse CD24-FITC (BD Biosciences, San Diego,
CA) for an hour. For each sample, cells (0.5x106 cells) were
mixed with incubation buffer and the isotype control (rat IgG2b-
FITC, AbD Serotec, Kidlington, UK) for the same duration. After
centrifugation (600 rcf, 6 minutes) and supernatant removal,
iPSCs were washed and re-suspended in labeling buffer (1X
DPBS without Ca2+ and Mg2+, 0.5% BSA, 2 mM EDTA) and
anti-FITC microbeads (Miltenyi Biotec, Bergisch Gladbach,
Germany) for 30 minutes.
The MiniMACSTM kit (Miltenyi Biotec) was used to sort for
CD24-positive cells using the MiniMACSTM separator and
MACS magnetic column. This column was rinsed with
separation buffer before loading of the iPSC suspension. Three
flushes with separation buffer (1X DPBS without Ca2+ and Mg2+,
0.5% BSA, 2 mM EDTA, degassed) resulted in the collection of
a “flow-through” volume consisting of unlabeled cells (CD24
negative, CD24-). Meanwhile, magnetically labeled cells were
retained on the MACS column and subsequently eluted via a
plunger (CD24 positive, CD24+). The small amount of cells
(~10,000) from both CD24+ fractions and the “flow-through”
fraction (CD24-), along with a presorted sample, were analyzed
with a flow cytometer (Accuri C6) for the percentage of cells
expressing CD24. In general, this CD24 sorting protocol was
able to provide an approximately five-fold enrichment for the
percentage of CD24 expressing cells (59-85%) in the sorted
fraction as compared to presorted cells (12-17%). Generally,
the amount of CD24-expressing cells in the “flow-through”
fraction were found to be less than 5% of total cells
demonstrating excellent capture of CD24+ cells within the
magnetic column (Figure 2). A minimum of six independent
sorting experiments were performed in order to collect enough
both CD24- cells in “flow-through” and sorted CD24+ cells for
gene expression analysis and for 3D culture of CD24+ enriched
cell populations.
RNA Isolation and Realtime RT-PCR
Total RNA was extracted from cells in the following groups
(Group I: undifferentiated iPSCs and cells in EBs for 3 days,
n=2; Group II, unsorted iPSCs, CD24- cells in “flow-through”
and sorted CD24+ cells immediately after cell sorting, n=3) with
the RNAeasy kit plus DNase I digestion (Qiagen, Valencia, CA,
USA), as previously described [56]. For quantitation of mRNA,
two human-specific PCR primers and one fluorescently labeled
intron-spinning probe were used for each target gene (Applied
Biosystems, Foster City, CA, Table 2), with amplification
conditions used as previously described [56]. Relative gene
expression differences were quantified between the control
(undifferentiated or pre-sorted iPSCs) and treatment group (EB
or CD24- or CD24+ iPSCs) using the comparative Ct method
with β2-microglobulin (B2m) as the internal control. The
expression of this housekeeping gene was stable during
differentiation of iPSCs according to our preliminary analysis.
The relative mRNA level of undifferentiated cells or presorted
cells was set as the calibrator (value=1) and EB cells or sorted
CD24+ cells were normalized based on this value. Duplicate
PCR reactions were performed for each target gene and the
internal control for one RNA sample. Statistical analyses were
performed to detect a difference in ΔCt (Ct of target -Ct of B2m)
values between presorted and sorted CD24+ or CD24- samples
for each target gene using a one-factor ANOVA (StatView,
SAS Institute, Cary, NC). Fold-differences in relative mRNA
levels (2-∆∆Ct) between control (presorted cells) and sorted
samples (CD24+ or CD24-) were reported if greater than or
equal to 2, and where ANOVA detected a difference at p<0.01
[56].
Differentiation experiment I: an enriched CD24+ iPSC
population cultured in vitro
As outlined in Figure 2A, both CD24- cells in “flow through”
and enriched CD24+ iPSCs via MACS were allowed to
differentiate in a laminin-rich culture substrate previously
Differentiation of iPSCs into NP Cells
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Figure 1.  iPSC morphology and the expression notochordal-related transcriptional factors.  (A) Undifferentiated iPSCs
cultured on a feeder layer of mitotically inactivated mouse embryonic fibroblasts and formed colonies (top panels); iPSCs formed
cell clusters of embryoid bodies (EBs, bottom panels) when promoted to undergo spontaneous differentiation in ultra-low attaching
dishes (bars = 100 µm). (B) Relative mRNA levels for transcriptional factors (Oct4, Noggin, Brachyury, Noto, Foxa2, Shh) in EBs (3
days) normalized to undifferentiated iPSCs for each target gene. Data are averages of two replicates for cells collected from multiple
EBs and undifferentiated culture.
doi: 10.1371/journal.pone.0075548.g001
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shown to promote the formation of a three-dimensional cell
clusters. Briefly, 60 µL of MatrigelTM (BD Biosciences, San
Jose, CA) was coated onto 6.5 mm diameter Costar Transwell
inserts (Corning), and let set at 37°C for 2 hours. Immediately
after sorting, the CD24- and CD24+ fractions of iPSCs were
seeded onto the Matrigel-coated surfaces at 1x106 cells per
insert (n=3) arranged in a 24-well plate. Both cell types have
been observed to cluster into large cell pellets (or 3D construct)
within 24 hours at these conditions [54] that are stable over
long periods of culture. Cell constructs were cultured under
normoxic conditions (21% O2) for up to 28 days in NP
differentiation medium: DMEM/ F-12 with 15 mM HEPES, L-
glutamine, and pyridoxine hydrochloride (1:1, v/v; Life
Technologies), with additional L-ascorbic acid-2-phosphate
(sterilized using a 0.22 µm filter; Sigma), non-essential amino
acids, insulin transferrin-selenium (ITS) and penicillin-
streptomycin (all from Life Technologies). Medium both outside
and inside the inserts was changed biweekly for the duration of
cell culture.
Differentiation experiment II: iPSCs cultured under
hypoxic conditions
Transwell inserts were coated with MatrigelTM as described
above. When nearly confluent, tissue culture flasks of
proliferated iPSCs were transferred to a low-oxygen humidified
environment (2% O2, 37°C) for a 24-hour period. Following this
protocol for hypoxic conditioning, cells were gently detached
using 0.025% trypsin/EDTA (Lonza, Walkersville, MD) and
seeded onto Matrigel-coated Transwells (n=3) as described
above. They were then cultured in either equilibrated NP
differentiation medium (see above), or in equilibrated media
Table 1. Cell markers for NP phenotype analysis.
Antibody Vendor Host/type Isotype controlApplication
CD24 BD Biosciences Rt/mono Rt IgG2b FC and MACS
CD54 BD Biosciences Ha/mono Ha IgG1 FC
Integrin α3 (CD49c) R&D Systems Go/poly N/A FC
Integrin α5 (CD49e) BD Biosciences Rt/mono Rt IgG2a FC
Integrin α6 (CD49f) BD Biosciences Rt/mono Rt IgG2a IHC and FC
Integrin β1 (CD29) BD Biosciences Ha/mono Ha IgM FC
Integrin β4 (CD104) Serotec Rt/mono Rt IgG2a FC
CD31 BD Biosciences Rt/mono Rt IgG2a FC
CD34 BD Biosciences Rt/mono Rt IgG2a FC
CD45 Serotec Rt/mono Ra IgG2b FC
CD90 Serotec Ms/mono Ms IgG1 FC
Tie Biolegend Rt/mono Rt IgG1, k FC
GD2 BD Biosciences Ms/mono Ms IgG2a FC
Type II collagen DSHB Ms/mono Ms Igg IHC
Laminin α5 Santa Cruz Rb/poly NA IHC
Cytokeratin5/8 Santa Cruz Ms/mono Ms IgG1 IHC
Vimentin Santa Cruz Ms/mono Ms IgG1 IHC
Go: goat, Ha: hamster, Hu: human, Ms: mouse, Rb: rabbit, Rt: rat, IHC:
immunohistochemistry, FC: flow cytometryNA: not available; mono: monoclonal;
poly: polyclonal.
doi: 10.1371/journal.pone.0075548.t001
collected from immature NP tissue explant culture, termed
notochordal cell conditioned medium (NCCM). For generation
of NCCM media, immature porcine NP tissues containing
largely notochordal-like cells were incubated in DMEM-based
culture media under hypoxic conditions for 4 days as described
by Purmessur and co-workers [32]. At the end of the
incubation, the conditioned media was collected, concentrated,
and stored at -80°C until used as a supplement to iPSC culture.
For iPSCs cultured under these conditions, medium were
changed twice per week for up to 7, 14, 21 and 28 days in both
outside and inside the Transwell inserts. Similarly, iPSCs also
have been observed to cluster into large cell pellets (or 3D
construct) within 24 hours under hypoxia and NCCM culture
conditions that are stable over long periods of culture.
Histological evaluation for cell morphology and
proteoglycan composition
At the end of each time point, samples of cultured cell
constructs were embedded in OCT medium (Sakura Finetek,
Torrance, CA) and immediately flash-frozen in liquid nitrogen.
As a native IVD tissue control, lumbar IVDs were harvested
from a 1month-old mouse, then embedded and flash-frozen.
They were subsequently stored at -80°C until cryosectioning.
Frozen sections (7 µm) of IVD tissue and cell construct were
then fixed in 10% neutral buffered formalin (Azer Scientific,
Morgantown, PA) for 10 minutes, and washed in 1% lithium
carbonate solution (Mallinckrodt Chemicals, Phillipsburg, NJ)
and stained with 0.5% safranin-O solution (Sigma, St. Louis,
MO) for 60 seconds. Samples were rinsed with distilled water
and counterstained with Mayer’s Hematoxylin (Sigma) to
visualize individual cells. After serial steps of dehydration,
sections were then mounted with Permount (Fisher Scientific,
Pittsburg, PA) and visualized with light microscopy for intensity
of glycosaminoglycan staining.
Immunohistochemical staining for type II collagen
Frozen sections of IVD tissue and cell construct were
processed for immunohistochemical labeling of type II collagen
(HistoMouse-Plus kit, Invitrogen, Camarillo, CA) as described
previously [57]. Following peroxide-blocking, sections were
digested with pepsin (Digest-All 3, Life Technologies) for 10
minutes at 37°C. This enzyme helped expose the type II
collagen epitope recognized by the mouse monoclonal anti-
chicken antibody (II-II6B3, Developmental Studies Hybridoma
Bank, Iowa City, IA). Negative control sections were processed
in parallel with mouse IgG isotype control (Millipore) instead of
the primary antibody.
Immunohistochemical staining for NP-markers
Frozen sections of IVD tissue and cell construct were fixed in
4% formaldehyde (10 minutes at room temperature) prior to
labeling with antibodies detecting NP markers; for labeling of
the integrin α6 subunit, tissue sections were fixed in acetone
(10 min at -20°C). All fixed tissue sections were incubated with
a blocking solution (3.75% BSA/5% goat serum, Invitrogen) for
30 minutes, and then incubated for 2 hours with one of the
following antibodies: monoclonal or polyclonal anti-human
laminin α5 chain, vimentin, cytokeratin5/8, integrin subunit α6
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Figure 2.  Enrichment of CD24+ cell population from undifferentiated iPSCs via magnetic activated cell sorting (MACS).  (A)
General experimental overview. (B) Flow cytometry analysis for the expression of CD24 in presorted, “flow-through” and sorted cell
fractions. Undifferentiated iPSCs incubated with CD24 antibody and magnetic beads were passed through a MACS column, yielding
a CD24+ fraction of cells; in the “flow-through” fraction, ~ 5.1% of total cells on average were found to express CD24, which was less
than that in the presorted fraction. The gated readouts represent the percentage of cells expressed CD24 in presorted cells and
sorted fractions from one sorting experiment.
doi: 10.1371/journal.pone.0075548.g002
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(Table 1). Sections were washed twice in PBS and incubated
with appropriate secondary antibodies (AlexaFluor 488 or 633
secondary antibodies, Molecular Probes, Eugene, OR) for 30
minutes in blocking solution. Negative control sections were
incubated with appropriate isotype IgG controls (Table 1)
instead of primary antibody, or with secondary antibody alone
as a negative control (polyclonal antibodies). All sections were
counterstained with propidium iodide (0.2 mg/mL, Sigma) to
label cell nuclei, and imaged using confocal laser scanning
microscopy (Zeiss LSM 510; 20X NA 0.5 and 63X water
immersion NA 1.2 objectives; Carl Zeiss, Thornwood, NY).
sGAG content
Differentiated iPSC production of sulfated
glycosaminoglycans (sGAGs) was analyzed using the
dimethylmethylene blue (DMMB) spectrophotometric method
[58]. All samples of cell constructs were digested in papain
solution (300 µg/mL in PBS with 5mM EDTA and 5mM
cysteine, Sigma; 65°C for 16 hours) and the sample digest was
stored at -20°C. sGAG content in sample digest (40 µl) was
measured by mixing with DMMB dye solution (125 µl, 21µg/ml,
pH = 3; 2 replicates per sample) in a 96-well assay plate and
measuring absorbance (535nm) on a plate reader (Tecan
Genios, Mannendorf, Switzerland). sGAG concentrations were
calculated from absorbance using a standard curve prepared
from commercial chondroitin-4-sulfate (Sigma). Total sGAG per
sample was normalized to DNA content similarly measured in
sample digests (Quant-iT PicoGreen dsDNA Kit, Invitrogen).
Differences in sGAG content (sGAG/DNA) amongst control and
treatment groups at each time point were evaluated via two-
factor ANOVA, followed by Turkey’s post-hoc analysis at a
significance level of 0.05 (n=4).
Sircol collagen assay
Papain-digests were also analyzed for collagen content
samples using the Sircol Collagen Assay Kit (Biocolor;
Northern Ireland, UK). Digested samples (40µl) were incubated
with the Sircol Dye reagent for 30 minutes with gentle mixing,
then centrifuged (10,000 g for 10 minutes) to collect the
collagen-bound dye. Following supernatant removal, the pellet
was re-suspended in alkali reagent and transferred to a 96-well
assay plate for measuring absorbance (535nm, Tecan Genios)
with total collagen content calculated using a standard curve. A
Table 2. Probes and primers of notochordal-cell markers
analyzed by real-time RT-PCR (Applied Biosystems).
Target PCR probe/primers Order number
Noto Mm02345142_m1
Foxa2 Mm01976556_s1
Noggin Mm01297833_s1
Brachyury (T) Mm01318252_m1
Shh Mm00436528_m1
Oct4 Mm03053917_g1
β-2-microglobulin (B2m) Mm00437762_m1
doi: 10.1371/journal.pone.0075548.t002
negative control with only papain solution (40µl) was tested to
ensure that papain did not interfere with absorbance reading of
collagen assay. Two duplicate wells were measured for each
sample, and each collagen content value was normalized to
DNA content (as described above) for each sample.
Differences in total collagen production (collagen/DNA)
amongst control and treatment groups at each time point were
evaluated via two-factor ANOVA, followed by Turkey’s post-hoc
analysis at a significant level of 0.05 (n=3).
Results
iPSC derivation and characterization
Mouse embryonic fibroblasts were epigenetically
reprogrammed into induced pluripotent stem cells following
their transduction with an inducible expression polycystronic
lentiviral vector allowing the controlled expression of
transcription factors Oct4, Sox2, Klf4, and Myc [45]. Previous
results confirmed successful reprogramming of mouse
embryonic fibroblasts and the generated iPS cells expressed
proteins of pluripotency marker OCT4 (nuclear localization),
NANOG (nuclear localization), and SSEA1 (cell surface
localization) as determined by immunofluorescence [45]. In the
current study, the iPSCs proliferated and formed colonies on
mitotically inactivated MEFs feeder layers (Figure 1A, top).
When cultured in ultra-low attachment dishes without LIF for
spontaneous differentiation, iPSCs formed EB-like cell clusters
(Figure 1A, bottom) similar to embryonic stem cells.
Undifferentiated iPSCs and EBs (at 3days) expressed many
integrins (α3, α5, α6 and β1 subunits) and other NP markers
(CD24 and CD54) on their cell surface (Table 3). An elevated
percentage of cells expressed CD24 (NP cell marker), CD90
(mesenchymal stem cell marker) and CD31 (endothelia cell
marker) in EBs as compared to undifferentiated cells (Table 3).
Interestingly, about 10% of undifferentiated iPSCs expressed
Tie2, a recently identified marker for NP progenitor cells [13],
although its expression was declined in EBs (3%). It was noted
that the integrin β4 subunit, CD45, CD34 and GD2 (another
marker of NP progenitor cells [13]) were not expressed by
undifferentiated cells or by cells in EBs. In addition, EBs
expressed significant higher levels of mRNA for Noto, Foxa2
and Shh (notochordal genes) as compared to undifferentiated
cells (Figure 1B). Relative gene expression levels for
pluripotent marker Oct4 or nascent mesodermal marker
Brachyury decreased in EBs (Figure 1B).
An enriched CD24+ fraction of iPSCs
CD24+ cell fractions obtained from MACS as well as
presorted cells and CD24- cells in the “flow-through” fraction
were quantified by flow cytometry and analyzed for gene
expression of notochordal related transcription factors.
Following MACS, CD24+ iPSCs exhibited a 2 to 5-fold increase
in mRNA for Noto, Shh, Foxa2 and Brachyury, as compared
the presorted cells (Figure 3). Differences in mRNA for Noggin
were not detected following CD24+ selection. In contrast,
mRNA for Noto, Shh, Foxa2, Brachyury and Noggin was
decreased between 2 and 5-fold in CD24- cells of the “flow-
through” fraction, as compared to the presorted cells (Figure 3).
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These findings corroborate the identification of CD24+ as a
marker of the NP precursor cell that is associated with
expression of a set of signaling molecules and transcription
factors (Shh, Foxa2, Noto etc.) closely identified within
notochord [53,59-61].
Differentiation of enriched CD24+ iPSCs in vitro
Both CD24- and CD24+ cells formed large cell clusters upon
the laminin-rich (Matrigel) culture system within 24 hours, then
remained stable over time during culture. When cultured on this
soft gel substrate at 20% O2 and with differentiation media,
these cells formed cell clusters (Figure 4A, H& E staining),
expressed glycosaminoglycan (sGAG) (Figure 4A, Safranin-O
staining), and maintained a gelatinous morphology (Figure 4
A& B top) reminiscent of immature NP cells in situ for the
duration of culture [54]. Interestingly, only tissue sections from
CD24+ cell constructs showed abundant expression of type II
collagen (immunostaining, Figure 4A) which was not detected
in tissue sections of CD24- cells. In addition, we also detected
laminin α5 expression (immunostaining), although at very low
levels in CD24+ cell constructs (Figure 4B). Similarly, CD24+
cells within these constructs expressed some markers of the
immature NP cell phenotype including integrin α6 (known to
interact with laminins), vimentin and cytokeratin 5/8 (Figure
4B), while some positive expression for these NP-associated
markers were also detected in CD24- cells (data not shown).
Differentiation of iPSCs under hypoxic conditions
Studies were also undertaken to determine if unsorted iPSCs
could be promoted to differentiate into NP-like cells under
hypoxic culture conditions (2% O2), a condition commonly used
for NP cell culture and believed to mimic the in situ oxygen
tension [28]. In addition, comparison studies were performed to
Table 3. NP and MSC associated marker expression in
mouse iPSCs determined via flow cytometry analysis.
Marker
% Positive Cells
Undifferentiated
% Positive
Cells EB 3
days
Known cell
associations
CD24 17 28 NP
CD54 54 35 MSC, NP
CD49c (ITGα3) 22 9 MSC, NP
CD49e (ITGα5) 32 27 MSC
CD49f (ITGα6) 27 27 MSC, NP
CD29 (ITGβ1) 81 85 MSC
CD104 (ITGβ4) 0 3 NP
Tie 10 3 NP progenitor
GD2 0 0 NP progenitor
CD90 0 15 MSC
CD31 3 20 Endothelial
CD45 0 2 Leukocyte
CD34 0 1 Hematopoietic
Values represent an average percentage of cells expressing the markers (n = 2
samples, 104 cells per sample); ITG: integrin.
doi: 10.1371/journal.pone.0075548.t003
determine if this same population of iPSCs could be promoted
to differentiate into NP-like cells when cultured with factors
secreted by notochordal cell-containing NP tissue, or NCCM
(Figure 5A). When cultured on top of the laminin-rich (Matrigel)
substrate, iPSCs formed large cell clusters that were stable
over time during culture (Figure 5D top) and produced
significant amounts of sGAG and collagen (Figure 5B & C)
under hypoxic conditions, similar to that measured when using
the CD24+ cell fraction in culture under normoxic conditions.
The constructs cultured in NCCM produced significantly higher
levels of sGAG at all times, reflecting the higher composition of
anabolic growth factors in NCCM (Figure 5B). In contrast, few
differences were noted in collagen composition between the
control and the NCCM (Figure 5C). A prior study has shown
that anabolic factors in media conditioned by culture of anulus
fibrosus cells (immature porcine) produced equivalent levels of
biosynthesis in de-differentiated cells as did NCCM [55], so the
specificity of the anabolic factors to an NP cell source cannot
be inferred.
When iPSC cell constructs were cultured under hypoxic
conditions and with NCCM supplementation, some cells within
these constructs expressed several markers of the immature
NP cell phenotype, such as vimentin, cytokeratin 5/8 and
integrin a6 subunit, as compared to the control
(immunostaining, Figure 5D). Similarly, NCCM
supplementation also enhanced matrix accumulation as
indicated by Safranin-O staining for sGAG and immunostaining
for type II collagen from some parts of cells (Figure 5D). In
contrast to the CD24+ cell fraction in culture under normoxic
conditions, expression of laminin α5 in all cell constructs under
hypoxic conditions was not detected (data not shown). As a
positive control, NP-associated markers (integrin α6, cytokertin
5/8 and vimetin) were also found to be highly expressed in NP
cells but not in AF cells of immature mouse IVDs (Figure 5E).
Both type II collagen and Safranin-O staining were clearly
stained positive in this immature mouse NP tissue (Figure 5E).
Discussion
The results of this study demonstrate that a laminin-rich
culture environment may promote the differentiation of iPSCs
or enriched CD24+ iPSCs into a cell type exhibiting some NP-
like markers and immature NP morphology. ECM formation
(proteoglycans, type II collagen and laminin 511 in
differentiated CD24+ iPSCs) and the presence of several NP
markers (integrin α6 subunit, vimentin and cytokeratin 5/8)
were detected in the differentiated cells. These expression
patterns of NP-like markers and clustering morphology were
similar to those detected in immature NP tissue in situ (Figure
5E), primary NP cells and human umbilical cord-derived MSCs
cultured under a similar laminin-rich environment in our
previous studies [33,54]. While no complete set of markers has
yet been established for NP cells, findings of this study suggest
that iPSCs may be induced to differentiate into NP-like cells as
demonstrated by the presence of multiple NP-associated
markers. This is the first study in which iPSCs have been
shown to differentiate into NP-like tissue, capable of
synthesizing type II collagen and sGAG, as well as express
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various markers distinct to NP cell phenotype as confirmed in
native mouse NP tissue. The CD24+ cell population and
undifferentiated iPSCs cultured in NCCM exhibited features
characteristic of NP-like tissue, including integrin α6, and the
cell markers cytokeratins 5/8 and vimentin. Together with the
detection of type II collagen and sGAG, these studies show
accumulation of an NP-like matrix and retention of an NP-cell
phenotype that has not been demonstrated in other MSC
studies.
In vitro culture upon a Matrigel substrate was chosen here
for its demonstrated ability to promote NP cell attachment [8],
with the proposed mechanism that laminins within the Matrigel
may preferentially promote attachment of iPSCs to form NP
cells. It is known that immature NP cells reside in an unique
ECM environment rich in specific laminin isoforms (LM511 and
LM322) and that they express high levels of laminin-binding
receptors (i.e. integrin α6 subunit) as compared to the
surrounding AF cells [6-8]. Previous studies have shown that
immature NP primary cells and human umbilical cord-derived
MSCs will maintain a clustered morphology when cultured
upon this laminin-containing Matrigel substrate [33,54], that
may work to promote maintenance of the NP cell phenotype.
Thus, recreation of this feature of the immature NP ECM
environment, along with the soft stiffness of Matrigel substrate
that matches that of the native NP [54], may have contributed
to the directed differentiation of iPSCs here. Previously,
laminin-containing substrates were found to enhance adult
MSC differentiation to adipocytes [50] and human ESC
differentiation into neurons [62], although with defined culture
media that included lineage-specific growth factors or other
inducers for adipogenesis and neural differentiation. A recent
study of finding a population of multipotent progenitors from NP
Figure 3.  Relative mRNA levels in undifferentiated, presorted iPSC populations, “flow-through” and sorted CD24+ fractions
for notochordal markers (Noto, Shh, Foxa2, Brachyury and Noggin).  Data are expressed as fold-difference (2-ΔΔCt, n=3
independent sorting experiments, mean+SE) between sorted CD24+ or “flow-through” and presorted samples. The relative mRNA
level in presorted cells was set as the calibrator (value=1) for normalizing the relative mRNA levels in the CD24+ cell fraction and
“flow-through” fraction (* p<0.01, ANOVA: significant fold-difference detected between presorted cells and CD24+ cells or CD24-
cells in “flow-through”, and between CD24- cells in “flow-though” and CD24+ cells). Differences were detected in all targets except
for Noggin between unsorted cells and sorted CD24+ cells.
doi: 10.1371/journal.pone.0075548.g003
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tissue made use of methylcellulose as a substrate [13], which
has mechanical properties that match that of the Matrigel used
here. Still, this prior work made use of serum supplementation
but not laminin ligand presentation such that the culture
microenvironment was quite distinct from that used here. We
can conclude that the interaction of multiple factors that include
ECM proteins and cell-ligand engagement, as well as growth
factor supplementation and substrate stiffness, appear to be
important for promoting iPSC differentiation into NP-like cells in
vitro in our current study.
Directed differentiation for enriched CD24+ iPSCs was done
without any growth factor supplementation, as is commonly
applied for chondrogenesis with use of ESCs or iPSCs. Clearly,
the finding of collagen II only detected in CD24+ cells indicated
that CD24+ cells were differentiated into cells with more
chondrogenic potential than CD24- cells. In addition,
differentiation of unsorted iPSCs was tested under both
hypoxic conditions and with NCCM supplementation. In fact,
NCCM generated from native NP tissues may be expected to
contain many soluble factors including TGFβ, BMPs and other
growth factors which commonly present in IVD tissues [63],
such that culture with NCCM would have been expected to
promote a more chondrogenic phenotype. In one study,
connective tissue growth factor has been identified in NCCM
Figure 4.  Differentiation of enriched CD24+ iPSCs in a 3D culture system in vitro.  (A) Cell constructs form both CD24- and
CD24+ fractions extracted from Transwells at the end of culture (day 28) and representative images of histology and immunostaining
revealed cell morphology (H and E) and matrix accumulation (Saf O for glycosaminoglycan and type II collagen, Col II; Scale bar: 50
µm). (B) CD24+ cell construct and representative images for expression of NP-associated markers by immunostaining (integrin α6,
ITGα6; laminin α5, LM α5; vimentin, VIM and cytokeratin 5/8, CK) in cell constructs at day 28. Scale bar: 20 µm).
doi: 10.1371/journal.pone.0075548.g004
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and has been shown to act as an anabolic factor, promoting
aggrecan gene expression in primary NP cells [64]. Similarly,
NCCM has been shown to promote MSC differentiation into
NP-like cells and to enhance gene expression of matrix
proteins in MSCs, aged human NP cells and porcine IVD cells
[31,32,55,65]. Indeed, we saw that NCCM had a significant
effect in mediating iPSC differentiation and promoting the
accumulation of more NP-like matrix. However, the enriched
CD24+ cells were also capable of synthesizing NP-like matrix,
with only the culture conditions (without growth factors) being
Figure 5.  Differentiation of iPSCs under hypoxic conditions in vitro.  (A) General experimental overview. (B) Sulfated-
glycosaminoglycan content normalized to DNA content (sGAG/DNA) in cell constructs (results shown as mean+SD, n=3 samples).
Significant effects of treatment and time were detected using a two-way ANOVA and Tukey’s HSD (p<0.05). Treatment and time
points denoted by different letters were found to be significantly different: uppercase letters for treatment; lowercase letters for time.
(C) Total collagen content normalized to DNA (collagen/DNA) in cell constructs (results shown as mean+SD or –SD, n=3 samples).
No significant effects of treatment on collagen production were detected via two-way ANOVA and Tukey’s HSD (p>0.05). (D) Cell
constructs extracted from Transwelsl at the end of the culture (day 28) and representative images of histology and immunostaining
revealed matrix accumulation (Saf O for glycosaminoglycan and type II collagen, Col II; Scale bar: 100 µm) and expression of NP-
associated markers (vimentin, VIM; cytokeratin 5/8, CK and integrin α6, ITGα6) in cell constructs at days 28. Scale bar: 50 µm.
NCCM: notochordal cell conditioned medium. (E) Representative images of histology (H and E) and immunostaining for above
mentioned NP-associated markers and matrix proteins in the immature mouse IVD (1 month-old) tissue control (AF: anulus fibrosus;
NP: nucleus pulposus).
doi: 10.1371/journal.pone.0075548.g005
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the dominant driver of differentiation and matrix production.
Supplementation with NCCM seemed to improve matrix
synthesis, notably the accumulation of sGAG that is considered
important for regenerating the NP – a structure abundant in
proteoglycans. These findings for NCCM-cultured iPSC
constructs, which were already at levels reported for porcine
NP cells cultured on Matrigel in our previous study [54]. Total
collagen synthesis did not depend on treatment type, however,
but varied significantly over time (days 7 and 14 > days 21 and
28). It is suspected that an appreciable amount of collagen may
have been released into the surrounding culture environment
during the differentiation process. Validation of this will involve
collecting culture media at various time points and repeating
biochemical quantification.
Previous studies have demonstrated that distinct cell
populations (i.e., ESC-derived pancreatic progenitors, epithelial
cells-drived MSCs) may be isolated via CD24 sorting [66,67].
CD24 has also been identified as a marker of NP cells [11] and
of progenitor cells in NP [13]. The current study showed that
mouse iPSCs express CD24, albeit at low cell numbers. These
observations provided the impetus for MACS to obtain an
enriched CD24+ fraction of mouse iPSCs. CD24 was
corroborated as an immature NP cell marker through the
identified upregulation of mRNA for Noto, Shh, Foxa2 and
Brachyury notochordal markers indicating a potential NP cell
lineage in this enriched CD24+ fraction of iPSCs as compared
to CD24- cells. CD24+ selection alone proved sufficient to
insure accumulation of matrix with abundant type II collagen
although NP-associated markers (integrin α6, laminin, and
cytokeratins 5/8 and vimentin) were also detected in CD24-
cells. While some similar expression patterns were observed
for the unsorted iPSCs cultured in NCCM, this strategy of
sorting cells prior to directed differentiation can have
advantages over the use of stem cells directly, that can enable
differentiation into a specific lineage and also reduced tumor
genic potential. A previous study using a similar sorting
strategy based on type II collagen gene expression has led to a
much higher quality of iPSC-derived cartilage tissue [47]. One
drawback of MACS is the requirement for a large starting cell
number to obtain reasonable numbers of the enriched cell pool,
for both gene expression analysis and 3D culture experiments.
We posited that this CD24+ subpopulation could proliferate if
reseeded onto a T75 flask and passaged thereafter to maintain
a line of CD24+ iPSCs. However, that fraction did not readily
expand in culture and was characterized by low viability in our
pilot experiments (data not shown). Thus, the results currently
support the concept of directed differentiation of sorted CD24+
iPSCs only immediately after selection. However, additional
tests are needed to ensure that no ESC markers (i.e. Nanog)
express in CD24+ cells in order to minimize any tumorigenic
potential in the development of a therapeutic application.
Furthermore, the differentiated CD24- iPSCs also expressed
some NP-associated markers suggesting that selecting iPSCs
with MACS via CD24 only can enrich, but not uniquely select
progenitors for NP cells. Nevertheless, the current study is a
first step towards future work that may rely upon use of two or
three markers for selecting iPSCs with potential to differentiate
into NP cells of notochordal lineage.
Sakai and co-workers have suggested that Tie2 and GD2
expression are important cell-associated markers upstream of
CD24 expression in NP progenitor cells, and that all of these
markers may be used to sort cells for the NP progenitor
populations in both human and mouse NP [14]. Tie2 is a
tyrosine kinase receptor and is expressed in endothelial,
haematopoietic and neural stem cells [68], while GD2
(disialoganglioside) is a component of the plasma membrane
found mainly in the nervous system and is a marker for MSCs
derived from both bone marrow and umbilical cord [69,70]. In
the current study, we identified that about 10% of
undifferentiated mouse iPSCs expressed Tie2 and 17% of
iPSCs expressed CD24, but no expression of GD2 was
detected in mouse iPSCs at the undifferentiated stage. It is
possible that GD2 may be downstream of Tie2 and CD24
expression during mouse iPSC differentiation. Further studies
that use sorting for Tie2+ or even GD2+ cells from iPSC
populations at an early time point of differentiation for NP-genic
progenitors may elucidate the functional roles and relationships
of these three NP progenitor markers. Such an understanding
could enhance methods to direct differentiation of iPSCs to the
notchordal or NP cell lineage.
The mouse iPSCs used in the current study were generated
via the use of viral vectors and characterized previously for
iPSC-derived cardiac progenitor differentiation to
cardiomyocytes [45]. In that study, the pluripotent potential of
the undifferentiated iPSCs was confirmed through detection of
pluripotency marker expression and generation of smooth
muscle, cartilage and endothelial cells in vitro [45]. The ability
of these iPSCs to form teratomas has not yet been tested [45],
although teratomas were successfully formed from another
mouse iPSC line derived using a similar protocol [47]. In the
current study, we are interested in the potential of mouse
iPSCs to differentiate into NP-like cells with notochordal
lineage that we define through a subset of known cell-
associated markers. This may represent the first demonstration
of differentiation into cells of a notochordal lineage, and
definition of culture conditions that may promote this
differentiation for iPSCs. Our ultimate goal is to be able to
identify a reliable fraction of NP-genic progenitors from iPSCs
with efficient cell sorting and to use these progenitors in cellular
therapy for disc repair.
In summary, this study evaluated a novel mouse iPSC cell
source and its potential use for differentiation into a well-
defined NP cell phenotype. The results demonstrate that an
enriched CD24+ fraction of iPSCs can be directed toward an
NP-like phenotype as evidenced by the expression of NP-like
cell clustering morphology and accumulating NP-like matrix in
the absence of growth factor supplementation. The results also
demonstrate that unsorted iPSCs can be differentiated to an
NP-like cell phenotype when cultured with supplemental
conditioned media obtained from native NP tissues, and under
hypoxic conditions. These studies are the first to report the
expression of NP cell-associated markers in an iPSC cell type
under undifferentiated and sorted (CD24+) conditions, and after
spontaneous differentiation and in vitro culture. The findings lay
the groundwork for future studies that can further refine cell
sorting and culture conditions and definitions of the NP cell
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phenotype to advance use of iPSCs for intervertebral disc
tissue repair and regeneration.
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